Stéphane Postic
Finanzdirektor/CFO bei MEDINCELL S.A.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sabri Markabi | M | - | 7 Jahre | |
| Christophe Douat | M | 60 | 21 Jahre | |
| Grace Kim | M | - | 1 Jahre | |
| Julie Alimi | F | - | 3 Jahre | |
| Philippe Guy | M | - | 14 Jahre | |
| Antoine Andremont | M | - |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 24 Jahre |
| David Heuzé | M | - | 9 Jahre | |
| Adolfo Lopez-Noriega | M | - | 9 Jahre | |
| Franck Pouzache | M | - | 4 Jahre | |
| Pierre-Alain Bandinelli | M | - |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | - |
| Nicolas Merigeau | M | - | - | |
| Christophe Roberge | M | - | 16 Jahre | |
| Elisabeth Kogan | F | - | 4 Jahre | |
| Sébastien Magnat | M | - | 8 Jahre | |
| Sébastien Enault | M | - | - | |
| Richard Malamut | M | 64 | 2 Jahre | |
| Virginie Lleu | F | - | 8 Jahre | |
| Tone Kvåle | F | 55 | 2 Jahre | |
| Nicolas Gourgues | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Anh Nguyen | M | - | 21 Jahre | |
| Mohammed Khoso Baluch | M | 66 |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stéphane Postic
- Persönliches Netzwerk
